Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 7.7808
-1.91 %
$ 200 M
Market Cap
-12.61
P/E
NEO - REVENUE
Revenue NEO - NeoGenomics, Inc.
661 M
LAST VALUE
13.84%
2 YEAR CAGR
10.07%
5 YEAR CAGR
22.46%
10 YEAR CAGR